StratDeck

Two stocks in Healthcare

Bristol-Myers Squibb vs Vertex Pharmaceuticals: profit, growth, debt and price compared

Vertex Pharmaceuticals is stronger on 4 of 6 figures: profit margin, sales growth, debt and price trend. Bristol-Myers Squibb is stronger on 1: price for its expected profit.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Bristol-Myers Squibb's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Bristol-Myers Squibb and Vertex Pharmaceuticals side by side
Bristol-Myers SquibbBMYVertex PharmaceuticalsVRTX
Net margin18.5%Stronger: 30.7%
Revenue growth, past year+6.93%Stronger: +11.85%
Debt to equity191.5%Stronger: 31.0%
Forward P/EStronger: 8.9×26.9×
Dividend yield4.23%—
AnalystsBuy · 24Buy · 28
From its 200-day average+1.2%Stronger: +8.8%

Share price over the past year

  • Bristol-Myers Squibb+26.6%
  • Vertex Pharmaceuticals+23.2%

18 Nov 202518 Nov 2026

Bristol-Myers Squibb or Vertex Pharmaceuticals: which is stronger?

  • VRTX

    Which is more profitable?

    Vertex Pharmaceuticals keeps more of each sale as profit: 30.7% against 18.5%.

  • VRTX

    Which is growing its sales faster?

    Vertex Pharmaceuticals is growing its sales faster: +11.85% over the past year, against +6.93%.

  • VRTX

    Which has borrowed less?

    Vertex Pharmaceuticals has borrowed less: its debt is 31.0% of what its shareholders own, against 191.5% for Bristol-Myers Squibb.

  • BMY

    Which costs less for the profit it is expected to make?

    Bristol-Myers Squibb costs less for the profit it is expected to make: 8.9× its forward earnings, against 26.9×.

  • Which pays more in dividends?

    Bristol-Myers Squibb pays 4.23% a year in dividends for what a share costs, where Vertex Pharmaceuticals pays none.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • VRTX

    Which is in the stronger price trend?

    Vertex Pharmaceuticals' price is in the stronger trend: 8.8% above its 200-day average, against 1.2% above.

What each company does

BMYBristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Reports results on 4 February 2027

VRTXVertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.

Reports results on 11 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.